| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
| AZN |
AstraZeneca
|
FTSE 100
| 1.95 |
£193.37B
| 12,364.00 | -0.85% |
| GSK |
GSK
|
FTSE 100
| 3.43 |
£72.3B
| 1,757.00 | -1.32% |
| HLN |
Haleon
|
FTSE 100
| 1.92 |
£31.54B
| 357.70 | 1.02% |
| SN. |
Smith & Nephew
|
FTSE 100
| 2.06 |
£11.92B
| 1,396.00 | -0.64% |
| CTEC |
ConvaTec Group
|
FTSE 100
| 2.06 |
£4.86B
| 238.80 | -2.21% |
| HIK |
Hikma Pharmaceuticals
|
FTSE 100
| 3.48 |
£4.08B
| 1,821.00 | -0.98% |
| HCM |
Hutchmed China
|
AIM
| |
£1.89B
| 227.50 | 4.80% |
| GNS |
Genus
|
FTSE 250
| 1.30 |
£1.64B
| 2,510.00 | 2.03% |
| INDV |
Indivior
|
FTSE 250
| |
£1.54B
| 1,238.00 | -3.10% |
| SPI |
Spire Healthcare Group
|
FTSE 250
| 0.98 |
£944.47M
| 233.00 | -0.64% |
| UPR |
Uniphar
|
AIM
| 0.01 |
£873.06M
| 334.00 | 0.90% |
| OXB |
Oxford BioMedica
|
FTSE Small Cap
| |
£789.76M
| 654.00 | -0.46% |
| AMS |
Advanced Medical Solutions Group
|
AIM
| 1.25 |
£463.5M
| 217.00 | 3.10% |
| AGY |
Allergy Therapeutics
|
AIM
| |
£412.3M
| 8.29 | -2.50% |
| PRTC |
Puretech Health
|
FTSE Small Cap
| |
£319.02M
| 129.80 | -1.67% |
| NIOX |
Niox Group
|
AIM
| 1.82 |
£287.5M
| 68.00 | |
| AVCT |
Avacta Group
|
AIM
| |
£272.08M
| 73.08 | -7.00% |
| FARN |
Faron Pharmaceuticals OY
|
AIM
| |
£229.74M
| 207.00 | 1.10% |
| TSTL |
Tristel
|
Main Market
| 3.84 |
£176.66M
| 360.00 | 1.60% |
| ANCR |
Animalcare Group
|
AIM
| 2.07 |
£173.16M
| 246.00 | -2.60% |
| MXCT |
Maxcyte Inc
|
AIM
| |
£161.75M
| 147.69 | -1.20% |
| DXRX |
Diaceutics
|
AIM
| |
£142.18M
| 162.50 | -0.50% |
| BMK |
Benchmark Holdings
|
AIM
| |
£135.69M
| 22.05 | 1.50% |
| 4BB |
4basebio
|
AIM
| |
£122.27M
| 780.00 | -0.40% |
| EKF |
EKF Diagnostics Holdings
|
AIM
| |
£116.95M
| 26.90 | 1.00% |
| BVXP |
Bioventix
|
AIM
| 7.32 |
£107.11M
| 2,176.34 | -2.20% |
| ANP |
Anpario
|
Main Market
| 2.32 |
£102.98M
| 495.10 | -0.90% |
| SCLP |
Scancell Holdings
|
AIM
| |
£102.22M
| 9.82 | -1.10% |
| SDI |
SDI Group
|
AIM
| |
£87.3M
| 84.75 | -1.50% |
| ANIC |
Agronomics
|
AIM
| |
£77.73M
| 8.12 | -0.60% |
| STX |
Shield Therapeutics
|
AIM
| |
£70.61M
| 7.18 | -7.90% |
| SPEC |
Inspecs Group
|
AIM
| |
£63.04M
| 64.00 | -0.30% |
| OBI |
Ondine Biomedical Inc
|
AIM
| |
£58.86M
| 13.00 | 2.60% |
| IMM |
ImmuPharma
|
AIM
| |
£58.32M
| 10.40 | -3.00% |
| EAH |
Eco Animal Health Group
|
AIM
| |
£56.24M
| 82.33 | -4.30% |
| CREO |
Creo Medical Group
|
AIM
| |
£45.28M
| 11.50 | -0.80% |
| HVO |
Hvivo
|
AIM
| 3.04 |
£44.77M
| 6.53 | -5.10% |
| KMK |
Kromek Group
|
AIM
| |
£43.88M
| 6.88 | 8.70% |
| SBTX |
SkinBioTherapeutics
|
AIM
| |
£41.73M
| 16.14 | -14.90% |
| OHGR |
One Health Group
|
AIM
| 0.03 |
£32.63M
| 238.00 | |
| NCYT |
Novacyt SA
|
AIM
| |
£27.87M
| 40.17 | 4.20% |
| AREC |
Arecor Therapeutics
|
AIM
| |
£27M
| 75.00 | -1.30% |
| ABDX |
Abingdon Health
|
AIM
| |
£26.09M
| 6.36 | 2.60% |
| POLB |
Poolbeg Pharma
|
AIM
| |
£25.94M
| 3.71 | -2.10% |
| SAR |
Sareum Holdings
|
AIM
| |
£18.64M
| 14.67 | -5.60% |
| IHC |
Inspiration Healthcare Group
|
AIM
| |
£18.16M
| 20.60 | 0.60% |
| FAB |
Fusion Antibodies
|
AIM
| |
£15.34M
| 13.99 | 25.90% |
| COG |
Cambridge Cognition Holdings
|
AIM
| |
£14.23M
| 32.25 | -0.40% |
| EDEN |
Eden Research
|
AIM
| |
£13.33M
| 2.52 | -2.40% |
| GDR |
Genedrive
|
AIM
| |
£10.7M
| 0.96 | -1.60% |
| VRCI |
Verici Dx
|
AIM
| |
£10.59M
| 0.65 | -4.80% |
| IXI |
Ixico
|
AIM
| |
£10.43M
| 11.50 | -1.50% |
| CEL |
Celadon Pharmaceuticals
|
AIM
| |
£9.23M
| 13.40 | |
| GENI |
Genincode
|
AIM
| |
£8.32M
| 2.80 | 1.40% |
| OPTI |
OptiBiotix Health
|
AIM
| |
£8.26M
| 7.83 | -3.30% |
| FUM |
Futura Medical
|
AIM
| |
£8.09M
| 2.59 | 14.60% |
| AGL |
Angle
|
AIM
| |
£7.72M
| 2.40 | -0.70% |
| RUA |
RUA Life Sciences
|
AIM
| |
£7.45M
| 11.67 | -6.90% |
| OBD |
Oxford BioDynamics
|
AIM
| |
£6.26M
| 0.33 | -4.00% |
| PRM |
Proteome Sciences
|
AIM
| |
£5.36M
| 1.87 | 8.00% |
| SUN |
Surgical Innovations Group
|
AIM
| |
£5.36M
| 0.55 | -2.30% |
| TRX |
Tissue Regenix Group
|
AIM
| |
£5.16M
| 7.25 | -1.50% |
| MHC |
MyHealthChecked
|
AIM
| |
£4.68M
| 9.25 | 5.30% |
| BELL |
Belluscura
|
AIM
| |
£3.01M
| 0.75 | -1.10% |
| GUN |
Gunsynd
|
AIM
| |
£1.97M
| 0.14 | 9.50% |
| POLX |
Polarean Imaging
|
AIM
| |
£1.87M
| 0.15 | -3.20% |
| PYC |
Physiomics
|
AIM
| |
£1.29M
| 0.41 | -3.80% |
| VAL |
ValiRx
|
AIM
| |
–
| 0.25 | -2.20% |
| TLY |
Totally
|
AIM
| |
–
| 0.24 | -1.90% |
| TRLS |
Trellus Health
|
AIM
| |
–
| 0.50 | 7.30% |